Lundbeck, UMMS to Collaborate on RNAi Therapeutic for Huntington's Disease
February 03, 2011
Lundbeck, UMMS to Collaborate on RNAi Therapeutic for Huntington's Disease
Although Lundbeck's foray into the RNAi drugs scene is modest compared with investments made by other pharmas, it comes at a time when many of those firms have put the brakes on their commitment to the approach.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.